Parvoruvax inj. susp. i.m. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Erysipelothrix rhusiopathiae (inactivated) >= 1 ELISA U/dose; Porcine parvovirus (inactivated)

Available from:

Ceva Santé Animale SA-NV

ATC code:

QI09AL01

INN (International Name):

Erysipelothrix Rhusiopathiae; Porcine Parvovirus

Pharmaceutical form:

Suspension for injection

Composition:

Erysipelothrix Rhusiopathiae; Porcine Parvovirus

Administration route:

Intramuscular use

Therapeutic group:

pig

Therapeutic area:

Porcine Parvovirus + Erysipelothrix

Product summary:

CTI code: 147515-01 - Pack size: 5 doses (10 (10) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 570933-01 - Pack size: 50 doses (100 (100) - Commercialisation status: YES - Delivery mode: Medical prescription; CTI code: 147515-02 - Pack size: 25 doses (50 (50) - Commercialisation status: YES - CNK code: 1202225 - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

1989-05-22